The NeuroCognitive Research Institute (NCRI) is back in business, and we are once again supporting the myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS) populations through research and clinical assessments.
Our institute offers comprehensive neurocognitive assessment and clinical reports, which can be used for treating patients, assisting with disability claims and conducting research.
We are also currently conducting a research study on people with ME and CFS by using neuroimaging to evaluate the nature and extent of cognitive impairment in patients. Read more.
We now offer swLORETA assessment for identifying brain networks that are outside a normal range when compared to a normative database. When dysregulation in a particular network is linked to the symptoms, those brain areas may be targets for treatment aimed at reinforcing stability and efficiency within the network. This clinical efficacy is further enhanced by tailoring the treatment for each individual accordingly. (Read about our assessment process.)
The blue lines (edges) indicate reduced neural connectivity—the number and strength of the neural connections are greatly reduced (light blue) to severely reduced (dark blue). The red & yellow connections indicate compensation for weakened systems and are less differentiated and less efficient than normal. Edges which were normal are not shown.
This analysis demonstrates some of the issues that what everyone with ME experiences; this person would experience thoughts that seem to “vanish”, slowed cognition, difficulty in forming memories, reduced awareness overall and general loss of spontaneity.